Wespac Advisors So Cal, LLC Bristol Myers Squibb CO Transaction History

Wespac Advisors So Cal, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $24,273 - $26,840	-544 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $9,752 - $12,646	-200 Reduced 26.88%	544 $28,000
Q3 2018 Oct 22, 2018	BUY	$55.19 - $62.25 $41,061 - $46,314	744 New	744 $46,000
Q2 2018 Jul 13, 2018	SELL	$50.53 - $62.98 $27,488 - $34,261	-544 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $37,102 - $40,451	-619 Reduced 53.22%	544 $33,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,163	1,163 $64,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.